NICOLE MARKER-ZEWE: Open Payments
NPI 1619251055 · BRADFORD, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,251 in 66 payments from 17 companies in 2025. Trend: 2023 $1,599 · 2024 $1,266 · 2025 $1,251
Food & beverage: $1,251
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 10 | $210 |
| Merck Sharp & Dohme LLC | 10 | $162 |
| Edwards Lifesciences Corporation | 4 | $108 |
| Novo Nordisk Inc | 6 | $103 |
| Amgen Inc. | 6 | $98 |
| Boston Scientific Corporation | 4 | $90 |
| PFIZER INC. | 4 | $87 |
| Alnylam Pharmaceuticals Inc. | 5 | $86 |
| Novartis Pharmaceuticals Corporation | 4 | $69 |
| AstraZeneca Pharmaceuticals LP | 4 | $68 |
Products named: JARDIANCE, VERQUVO, Wegovy, REPATHA, ONPATTRO, LEQVIO, FARXIGA, VYNDAQEL.
Industry payments across PA — which companies pay providers there.
